Influences of antibiotics on biodiversity of intestinal microbiota in newborns
- Conditions
- intestinal floraMicrobiota1001796610004018
- Registration Number
- NL-OMON33555
- Lead Sponsor
- niversitair Medisch Centrum Groningen
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 50
Inclusion criteria Group 1
• Newborn infants born by vaginal delivery
• Without any complications during both intrauterine and intra partum period
• No antenatal/postnatal antibiotics
• Normal healthy infant
• Breastfed;Inclusion criteria Group 2
• Newborn infants born by vaginal delivery
• Without complications during both intrauterine and intra partum period except minor risk factors (GBS colonisation, unknown GBS status, Temp < 39°C) to prescribe antenatal antibiotics to the mother
• Antenatal antibiotics I.V. (2-8 hours before delivery)
• No postnatal antibiotics
• Normal healthy infant
• Breastfed;Inclusion criteria Group 3
• Newborn infants born by vaginal delivery
• Without any complications during both intrauterine and intra partum period
• No antenatal antibiotics
• Postnatal antibiotic therapy started within first 12 hours after birth and discontinued within 48-72 hours (discontinued course of antibiotics).
• Normal healthy infant with low risk for early onset sepsis
• Breastfed;Inclusion criteria Group 4
• Newborn infants born by vaginal delivery
• Without any complications during both intrauterine and intra partum period
• No antenatal antibiotics
• Postnatal antibiotic therapy started within first 12 hours after birth and discontinued after one week (full course of antibiotics).
• Normal healthy infant in whom an early onset sepsis could not be excluded.
• Breastfed;Inclusion criteria Group 5
• Newborn infants born by cesarean section
• Without any complications during both intrauterine and intra partum period
• No antenatal/postnatal antibiotics
• Normal healthy infant
• Breastfed
- APGAR Score after 5 minutes < 6
- Major congenital abnormality
- Congenital abnormonality of gastro intestinal tract
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Biodiversity of intestinal microbiota in newborns. </p><br>
- Secondary Outcome Measures
Name Time Method <p>The quantity of the specific bacteria in the intestinal microbiota of the<br /><br>newborn infant. </p><br>